Top Markets
Coin of the day
ContextVision AB (publ) ContextVision AB (publ)

ContextVision AB (publ)

0L8Z
Rankning i aktier #27954
ContextVision AB (publ), a Swedish medical technology company established in... ContextVision AB (publ), a Swedish medical technology company established in 1983 and headquartered in Stockholm, develops sophisticated image analysis and artificial intelligence software. These solutions are supplied to original equipment manufacturers (OEMs) across Asia, Europe, and the United States. The firm specializes in enhancing image quality for various medical imaging technologies, including 2D/3D/4D ultrasound, radiography, magnetic resonance imaging (MRI), and mammography. Key products in their lineup include Rivent, which delivers exceptional image clarity for diverse ultrasound applications such as women's health, general imaging, cardiovascular, and point-of-care. They also offer VolarView for improved visuals in handheld ultrasound devices, and GOPiCE, providing real-time volumetric image enhancement. Furthermore, ContextVision provides Altumira/Altumira Plus, a dedicated platform for digital radiography, alongside an Orthopedic Package for skeletal imaging. Their offerings extend to GOPView MRI2Plus for advanced MRI image refinement and INIFY Prostate Screening, a tool for the digital analysis of prostate biopsies.
Aktiekurs
$0.39098275
Senast synkroniserad: 2026-02-11
Marknadsvärde
$29.58M
Förändring (1 dag)
0.01%
Förändring (1 år)
-12.48%
Land
SE
Handel ContextVision AB (publ) (0L8Z)

Kategori

Aktiekurshistorik för ContextVision AB (publ) (0L8Z)
Högsta slutkurs: $0.39 den 2026-02-01

Lägsta slutkurs: $0.75 den 2017-03-01
Aktiekurshistorik för ContextVision AB (publ) från 2017 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -0.83%
2025 -18.06%
2024 -33.55%
2023 -21.96%
2022 -53.41%
2021 -4.17%
2020 217.00%
2018 -5.08%
2017 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$220.51 -19.05%
DE
$148.59 8.24%
CA
$206.02 -16.41%
US
$77.97 -16.82%
US
$127.32 -28.49%
US